![Stacie Weninger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stacie Weninger
President chez
Alzforum
Profil
Stacie Weninger is currently Director at Aratome, LLC; BRI-Alzan, Inc.; Bri-Tolan, Inc.; Digital Cognition Technologies, Inc.; Eikonizo Therapeutics, Inc.; Atalanta Therapeutics, Inc.; and Sironax Ltd. Dr. Weninger is President at Alzforum.
Dr. Weninger is Venture Partner at F-Prime, Inc. since 2009.
Formerly, Dr. Weninger was Director at Enspectra Health, Inc.; Inscopix, Inc.; Denali Therapeutics, Inc.; and Q-State Biosciences, Inc. Education includes undergraduate studies at The University of North Carolina at Charlotte and a doctorate from Harvard University conferred in 1999.
Postes actifs de Stacie Weninger
| Sociétés | Poste | Début |
|---|---|---|
Alzforum | President | - |
Aratome, LLC
 Aratome, LLC Miscellaneous Commercial ServicesCommercial Services Aratome, LLC specializes in advanced DNA-amplified multiplex immunofluorescence technology that enhances signal detection beyond conventional methods. The private company is based in Menlo Park. The American company ’ s patented approach uses DNA-tagged primary antibodies and cyclical, exponential amplification with branched fluorescent DNA structures to produce bright, stable, and controllable signals. This system supports multiplex staining with distinct oligo sets per channel, enabling simultaneous imaging of multiple antibodies regardless of species, and allows multiple rounds of staining with gentle fluorescent DNA removal. The technology is compatible with standard fluorescence microscopes and typical immunohistochemistry workflows, and is applicable to immunohistochemistry, immunocytochemistry, flow cytometry, western blots, bead assays, ELISA, and in situ hybridization. Aratome offers licensing opportunities for this technology across various research and clinical applications. | Directeur/Membre du Conseil | - |
BRI-Alzan, Inc. | Directeur/Membre du Conseil | - |
Bri-Tolan, Inc. | Directeur/Membre du Conseil | - |
Eikonizo Therapeutics, Inc.
 Eikonizo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops disease-modifying therapies to improve the lives of people by neurodegenerative, cardiorenal and other diseases | Directeur/Membre du Conseil | - |
Digital Cognition Technologies, Inc.
 Digital Cognition Technologies, Inc. Medical SpecialtiesHealth Technology Develops detect presymptomatic cognitive impairment and aid in tracking cognitive devices | Directeur/Membre du Conseil | - |
Atalanta Therapeutics, Inc.
 Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops RNA interference based therapeutics to treat neurodegenerative diseases | Directeur/Membre du Conseil | - |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Private Equity Investor | 01/02/2009 |
Sironax Ltd.
 Sironax Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Anciens postes connus de Stacie Weninger
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Stacie Weninger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Enspectra Health, Inc.
 Enspectra Health, Inc. Medical SpecialtiesHealth Technology Develops micro-endoscopy system for minimally invasive, real-time imaging of sarcomere | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inscopix, Inc.
 Inscopix, Inc. BiotechnologyHealth Technology Develops and produces miniature integrated microscopes and related devices | Health Technology |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Finance |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Alzforum | |
Aratome, LLC
Aratome, LLC Miscellaneous Commercial ServicesCommercial Services Aratome, LLC specializes in advanced DNA-amplified multiplex immunofluorescence technology that enhances signal detection beyond conventional methods. The private company is based in Menlo Park. The American company ’ s patented approach uses DNA-tagged primary antibodies and cyclical, exponential amplification with branched fluorescent DNA structures to produce bright, stable, and controllable signals. This system supports multiplex staining with distinct oligo sets per channel, enabling simultaneous imaging of multiple antibodies regardless of species, and allows multiple rounds of staining with gentle fluorescent DNA removal. The technology is compatible with standard fluorescence microscopes and typical immunohistochemistry workflows, and is applicable to immunohistochemistry, immunocytochemistry, flow cytometry, western blots, bead assays, ELISA, and in situ hybridization. Aratome offers licensing opportunities for this technology across various research and clinical applications. | Commercial Services |
BRI-Alzan, Inc. | |
Bri-Tolan, Inc. | |
Q-State Biosciences, Inc.
 Q-State Biosciences, Inc. BiotechnologyHealth Technology Develops optical electrophysiology platform for controlling and recording activity in electrically active cells | Health Technology |
Digital Cognition Technologies, Inc.
Digital Cognition Technologies, Inc. Medical SpecialtiesHealth Technology Develops detect presymptomatic cognitive impairment and aid in tracking cognitive devices | Health Technology |
Eikonizo Therapeutics, Inc.
Eikonizo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops disease-modifying therapies to improve the lives of people by neurodegenerative, cardiorenal and other diseases | Health Technology |
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops RNA interference based therapeutics to treat neurodegenerative diseases | Commercial Services |
Sironax Ltd.
Sironax Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
